AI Accelerates Drug Delivery Systems Design
A new AI framework called E-MAF has been developed to design controlled-release systems for drugs. This expert-mimic AI integrates a process-aware surrogate with an optimized genetic algorithm, enabling the generation of lab-ready designs tailored to desired release profiles in just one hour. The system successfully matches or exceeds commercial benchmarks across 7 active pharmaceutical…
1 source primary source
Key points
- E-MAF generates lab-ready designs in one hour
- Matches or exceeds commercial benchmarks across 7 active pharmaceutical ingredients
- Achieves release profiles difficult to achieve with conventional methods
Read the original at Nature Machine Learning primary sourceOpen source ↗
Topics · follow one to build your own front page
Huili Pharmaceutical Co., Ltd.E-MAF
The headline, key points and digest above were generated by Digest AI's editorial model from the linked sources. Automated summaries can contain errors: the sources are the record. Spotted a mistake? Tell us. Published by Martin K., who runs Digest AI and handles corrections.
More in Generative AI & Models
All →- Introducing Mistral Large 4 · 7 src
- OpenAI boosts GPT-6 speed by 50% in 28 Days update · 1 src
- Reflection AI debuts Beam, a 501B open-weight model rivaling GLM 5.2 with 3-4x less compute · 10 src
- Author tests four AI assistants on flawed forecasting scenarios · 1 src
- Anthropic prompts users to share voice data to enhance AI models · 8 src
Comments
via GitHub Discussions